BE857521A - Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane - Google Patents

Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane

Info

Publication number
BE857521A
BE857521A BE179934A BE179934A BE857521A BE 857521 A BE857521 A BE 857521A BE 179934 A BE179934 A BE 179934A BE 179934 A BE179934 A BE 179934A BE 857521 A BE857521 A BE 857521A
Authority
BE
Belgium
Prior art keywords
azolyl
butane
hydroxy
composition containing
microbial composition
Prior art date
Application number
BE179934A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE857521A publication Critical patent/BE857521A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE179934A 1976-08-07 1977-08-05 Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane BE857521A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762635665 DE2635665A1 (de) 1976-08-07 1976-08-07 Antimikrobielle mittel

Publications (1)

Publication Number Publication Date
BE857521A true BE857521A (fr) 1978-02-06

Family

ID=5984992

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179934A BE857521A (fr) 1976-08-07 1977-08-05 Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane

Country Status (6)

Country Link
US (1) US4215131A (fr)
JP (1) JPS5326329A (fr)
BE (1) BE857521A (fr)
DE (1) DE2635665A1 (fr)
FR (1) FR2360309A1 (fr)
GB (1) GB1545682A (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2811919A1 (de) * 1978-03-18 1979-09-27 Bayer Ag Acylierte 1-azolyl-2-hydroxy-butan- derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
DE3021551A1 (de) * 1980-06-07 1981-12-24 Bayer Ag, 5090 Leverkusen 4-substituierte 1-azolyl-1-phenoxy-3,3-dimethyl-butan-2-one und -ole, verfahren zu ihrer herstellung und ihre verwendung als fungizide
JPS5758671A (en) * 1980-09-25 1982-04-08 Ishihara Sangyo Kaisha Ltd Phenoxyalkylazole type compound and agricultural and gardening fungicide comprising it
DE3119390A1 (de) * 1981-05-15 1982-12-09 Bayer Ag, 5090 Leverkusen 3-substituierte 1-azolyl-3-methyl-1-phenoxy-butan-2-one und -ole, verfahren zu iher herstellung und ihre verwendung als fungizide
EP2147679B1 (fr) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions pour le transport de barrière hématoencéphalique
US20040191315A1 (en) * 2003-03-24 2004-09-30 Mike Slattery Office products containing antimicrobial agent
EP2392258B1 (fr) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Systeme pharma-informatique
CN101594878A (zh) 2006-09-18 2009-12-02 雷普特药品公司 通过给予受体相关蛋白（rap）-缀合物对肝病症的治疗
PL3395372T3 (pl) 2009-02-20 2022-07-25 EnhanX Biopharm Inc. Układ do dostarczania leków na bazie glutationu
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2041771C3 (de) * 1970-08-22 1979-07-26 Bayer Ag, 5090 Leverkusen derivate
DE2105490C3 (de) * 1971-02-05 1979-06-13 Bayer Ag, 5090 Leverkusen 1 -Imidazolylketonderivate
US4038404A (en) * 1972-09-26 1977-07-26 Bayer Aktiengesellschaft 1,2,4-triazole antimycotic compositions and use thereof
DE2324010C3 (de) * 1973-05-12 1981-10-08 Bayer Ag, 5090 Leverkusen 1-Substituierte 2-Triazolyl-2-phenoxyäthanol-Verbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung zur Bekämpfung von Pilzen
DE2423987C2 (de) * 1974-05-17 1986-01-16 Bayer Ag, 5090 Leverkusen Metallkomplexe von Azolyläthern, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Fungizide
DE2429514A1 (de) * 1974-06-20 1976-01-15 Bayer Ag Eckige klammer auf 1-imidazolyl-(1) eckige klammer zu- eckige klammer auf 1-(4'-(4''-chlorphenyl)-phenoxy eckige klammer zu-3,3-dimethyl-butan-2-on und seine salze, ein verfahren zu ihrer herstellung als arzneimittel
DE2635666A1 (de) * 1976-08-07 1978-02-09 Bayer Ag 1-azolyl-4-hydroxy-butan-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide und bakterizide

Also Published As

Publication number Publication date
DE2635665A1 (de) 1978-02-09
US4215131A (en) 1980-07-29
GB1545682A (en) 1979-05-10
FR2360309A1 (fr) 1978-03-03
FR2360309B1 (fr) 1980-04-18
JPS5326329A (en) 1978-03-11

Similar Documents

Publication Publication Date Title
BE855962A (fr) Essences contenant des additifs anti-depot
FR2301497A1 (fr) Composition d'engrais
FR2301899A1 (fr) Compositions de thermistan
FR2297883A1 (fr) Concentres contenant de l'amidon
BE841802A (fr) Composition de polypropylene
FR2348737A1 (fr) Preparation de compositions contenant des proteines
FR2315862A1 (fr) Compositions sucrantes contenant de l'arabinogalactane
AR223158A1 (es) Composicion de polimezcla
BE853296A (fr) Compositions contenant du platine
FR2339392A1 (fr) Compositions contenant des derives du silicium
BE840640A (fr) Teintures de la chevelure contenant des triaminopyrimidines comme revelateurs
BE857521A (fr) Composition anti-microbienne contenant des derives de 1-azolyl-4-hydroxy-butane
BE876701A (fr) Compositions stabilisees contenant des lactoproteines
FR2301253A1 (fr) Derives de la
IT1086674B (it) Composizione di trattamento dei capelli
BE836559A (fr) Compositions desinfectantes d'oxydiacetaldehyde
FR2352543A1 (fr) Composition de parfum
FR2350340A1 (fr) Derives de thiouree
BE856894A (fr) Composition antimicrobienne contenant des 1-imidazolyl-butane-2-ones ou -butane-2-ols halogenes
FR2332747A1 (fr) Derives d'a-aminocetones
BE866208A (fr) Derives de l'isoquinoleine hydrogenee
BE844909A (fr) Nouvelles compositions fongicides contenant des derives 1,2,4-triazoliques et des gibberellines
FR2298953A1 (fr) Compositions stabilisees de 2-alcoxyimino-n-carbamoyl-2-cyanoacetamides
FR2322604A1 (fr) Derives 3-triazolylthio d'ureido-7a-methoxy-ou demethoxycephalosporines
BE857629A (fr) Compositions stabilisees de 1,1,1-trichloroethane